Major pathologic response on biopsy (MPRbx) in patients with advanced melanoma treated with anti-PD-1: evidence for an early, on-therapy biomarker of response

Autor: Stein, J.E., Soni, A., Danilova, L., Cottrell, T.R., Gajewski, T.F., Hodi, F.S., Bhatia, S., Urba, W.J., Sharfman, W.H., Wind-Rotolo, M., Edwards, R., Lipson, E.J., Taube, J.M. *
Zdroj: In Annals of Oncology April 2019 30(4):589-596
Databáze: ScienceDirect